Citation Impact
50 standout
Citing Papers
Infectious Diseases Society of America 2024 Guidance on the Treatment of Antimicrobial-Resistant Gram-Negative Infections
2024 Standout
The Rise of Boron-Containing Compounds: Advancements in Synthesis, Medicinal Chemistry, and Emerging Pharmacology
2024 Standout
Works of Mark Lovern being referenced
Ceftazidime‐Avibactam Population Pharmacokinetic Modeling and Pharmacodynamic Target Attainment Across Adult Indications and Patient Subgroups
2018
A randomized, double blind, dose escalation, first time in human study to assess the safety, tolerability, pharmacokinetics, and antiviral activity of single doses of GSK2485852 in chronically infected hepatitis C subjects
2014
Author Peers
| Author | Epidemiology | Pharmacology | Infectious Diseases | Molecular Medicine | Last Decade | Papers | Cites |
|---|---|---|---|---|---|---|---|
| Mark Lovern | 120 | 134 | 50 | 109 | 21 | 477 | |
| Emil Boonacker | 41 | 6 | 73 | 1 | 7 | 485 | |
| S. Chowdhury | 8 | 110 | |||||
| Songmu Jin | 14 | 11 | 146 | 13 | 10 | 546 | |
| G. Hager | 20 | 6 | 2 | 22 | 807 | ||
| Carlo Cerini | 13 | 7 | 8 | 13 | 248 |
All Works
Loading papers...